EMB
CVS icon

Elefante Mark B’s CVS Health CVS Stock Holding History

Elefante Mark B’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		$324K Buy
4,979
+950
+24% +$59.8K 1.09% 34
2020
Q1 		$239K Hold
4,029
– – 1.04% 36
2019
Q4 		$299K Buy
4,029
+375
+10% +$26.3K 1.09% 36
2019
Q3 		$231K Sell
3,654
-1,528
-29% -$90.5K 0.91% 40
2019
Q2 		$282K Sell
5,182
-125
-2% -$6.73K 1.09% 33
2019
Q1 		$286K Sell
5,307
-994
-16% -$61.4K 1.25% 30
2018
Q4 		$413K Buy
6,301
+350
+6% +$26.1K 1.98% 23
2018
Q3 		$468K Sell
5,951
-300
-5% -$21.4K 1.87% 24
2018
Q2 		$402K Sell
6,251
-124
-2% -$8.17K 1.92% 25
2018
Q1 		$397K Sell
6,375
-200
-3% -$14.3K 1.99% 24
2017
Q4 		$476K Buy
6,575
+50
+0.8% +$3.63K 2.27% 21
2017
Q3 		$531K Buy
6,525
+125
+2% +$9.89K 3.87% 10
2017
Q2 		$515K Buy
6,400
+45
+0.7% +$3.55K 4.17% 9
2017
Q1 		$499K Buy
6,355
+1,020
+19% +$81.4K 4.53% 6
2016
Q4 		$421K Buy
5,335
+615
+13% +$49.8K 5.09% 5
2016
Q3 		$420K Sell
4,720
-790
-14% -$74.6K 6.78% 1
2016
Q2 		$527K Hold
5,510
– – 7.93% 2
2016
Q1 		$572K Buy
5,510
+1,970
+56% +$192K 9.13% 1
2015
Q4 		$346K Buy
+3,540
New +$347K 9.3% 1

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Elefante Mark B's CVS Position: Q2 2020 in Review

Elefante Mark B increased its CVS Health (CVS) stake by 24% in Q2 2020, buying an estimated $59.8K and bringing the position to 4,979 shares worth $324K. The position accounts for 1.09% of the portfolio, ranked #34.

Elefante Mark B first reported a position in CVS in Q4 2015 and has held it in 19 quarters since. The position peaked at $572K in Q1 2016. 1,864 funds tracked by Wall St. Rank hold CVS as of Q2 2020.

  • Elefante Mark B held 4,979 shares of CVS Health worth $324K as of Q2 2020.
  • Elefante Mark B bought 950 CVS Health shares in Q2 2020, an estimated $59.8K.
  • CVS Health made up 1.09% of Elefante Mark B's portfolio in Q2 2020, its #34 holding.
  • Elefante Mark B first reported a position in CVS Health in Q4 2015 and has held it in 19 quarters since.
  • Elefante Mark B's CVS Health position peaked at $572K in Q1 2016.
  • 1,864 funds tracked by Wall St. Rank held CVS Health as of Q2 2020.

Based on Elefante Mark B's 13F filing for Q2 2020, filed 28 Jul 2020.